Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elisabeth Suzanne Tabb, M.D.

Concepts (35)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Churg-Strauss Syndrome22022701.590 Why?
Neurosyphilis12022220.850 Why?
Hearing Loss, Bilateral12022540.840 Why?
Eosinophilia120225310.620 Why?
Asthma1202259240.230 Why?
Cogan Syndrome12022110.210 Why?
Treponema pallidum12022400.210 Why?
Audiometry120222410.200 Why?
Eye Diseases120226670.140 Why?
Diagnosis, Differential22022129940.140 Why?
Lyme Disease120226090.140 Why?
Hearing Loss, Sensorineural120227650.130 Why?
Glucocorticoids1202221050.110 Why?
Antigens, CD1202140310.100 Why?
Neoadjuvant Therapy1202026520.090 Why?
Carcinoma, Pancreatic Ductal1202015960.090 Why?
Carcinoma, Squamous Cell1202140240.070 Why?
Adenocarcinoma1202163810.060 Why?
Carcinoma, Non-Small-Cell Lung1202151530.060 Why?
Pancreatic Neoplasms1202052130.050 Why?
Leucovorin120206200.040 Why?
Lung Neoplasms12021129920.040 Why?
Lymphocytes, Tumor-Infiltrating1202110290.030 Why?
Fluorouracil1202016110.030 Why?
Humans520227369400.030 Why?
Middle Aged220222131150.020 Why?
Tumor Microenvironment1202134800.020 Why?
CD8-Positive T-Lymphocytes1202143980.020 Why?
Male220223490250.020 Why?
Prognosis12021289670.010 Why?
Antineoplastic Combined Chemotherapy Protocols12020113950.010 Why?
Treatment Outcome12020625010.010 Why?
Aged120201626790.000 Why?
Adult120202132830.000 Why?
Female120203785100.000 Why?
Tabb's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (35)
Co-Authors (18)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.